Skip to main content
Terug
Watch Compare

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Datakwaliteit: 83%
PACB
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 1,34
▼ € 0,01 (-0,74%)
Marktkapitalisatie: 412,23 M
Prijs
€ 1,37
Marktkapitalisatie
412,23 M
Dagbereik
52-Weeksbereik
Volume
Openen —
50D / 200D Gem.
50D / 200D Gem.

Quick Summary

Belangrijkste Punten

Negative free cash flow of -113,92 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-1119,86%
Onder sectorgemiddelde (-53,53%)
ROIC-58,12%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio6,24
Interest Coverage-79,65

Waardering

PE (TTM)
-0,75
Boven sectorgemiddelde (-1,48)
P/B Ratio11,42
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -1,5
P/B 11,4 1,6
ROE % -1119,9 -53,5
Net Margin % -41,5
Rev Growth 5Y % 1,8
D/E 0,3

Koersdoel Analisten

6 analisten
Hold
Huidig
€ 1,34
+92.8%
Koersdoel
€ 2,58
€ 1,50
€ 3,00
€ 3,00
Vooruitzicht
Forward K/W -3,25
Forward WPA -€ 0,41
Omzet Sch. 196,59 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,41
-€ 0,47 – -€ 0,24
196,59 M 7
FY2026 -€ 0,51
-€ 0,53 – -€ 0,47
174,38 M 7

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,13 -€ 0,12 +10,8%
Q32025 -€ 0,14 -€ 0,12 +15,1%
Q22025 -€ 0,17 -€ 0,13 +21,5%
Q12025 -€ 0,19 -€ 0,15 +20,5%

ETFs Holding This Stock

ARKG ARKG
1,95% weight
NXTE logo NXTE AXS Green Alpha ETF
0,45% weight
ARKK ARKK
0,41% weight
WDNA WDNA
0,31% weight
MEDX logo MEDX Horizon Kinetics Medical ETF
0,08% weight
GINN logo GINN Goldman Sachs Innovate Equity ETF
0,08% weight
WSMVX WSMVX
0,02% weight
DTSVX DTSVX
0,02% weight
VVICX VVICX
0,02% weight
IRSIX IRSIX
0,02% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -546,38 M
ROE -1119,86% ROA -67,10%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -113,92 M
ROIC -58,12% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6,24
Interest Coverage -79,65 Asset Turnover N/A
Working Capital 331,03 M Tangible Book Value -297,81 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,75 Forward P/E N/A
P/B Ratio 11,42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -27,64%
Market Cap 412,23 M Enterprise Value 355,76 M
Per Share
EPS (Diluted TTM) -1,82 Revenue / Share N/A
FCF / Share -0,38 OCF / Share -0,37
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20,85%
SBC-Adj. FCF -164,26 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue
Net Income -546,38 M -309,85 M -306,74 M -314,25 M -181,22 M
EPS (Diluted) -1,82 -1,59 -1,21 -1,40 -0,89
Gross Profit 45,78 M 37,28 M 52,78 M 49,04 M 58,86 M
Operating Income -553,86 M -474,31 M -334,47 M -307,20 M -210,44 M
EBITDA
R&D Expenses 97,31 M 134,92 M 187,17 M 193,00 M 112,90 M
SG&A Expenses 141,49 M 175,02 M 169,82 M 160,85 M 124,12 M
D&A
Interest Expense 6,95 M 13,41 M 14,34 M 14,69 M 12,53 M
Income Tax 318.000,0 316.000,0 -11,42 M -93,65 M -93,65 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 784,08 M 1,26 B 1,75 B 1,77 B 2,01 B
Total Liabilities 778,73 M 753,85 M 1,04 B 1,20 B 1,22 B
Shareholders' Equity 5,35 M 506,59 M 701,30 M 562,90 M 790,99 M
Total Debt 0,0 490.000,0 898,53 M 896,07 M
Cash & Equivalents 63,71 M 55,37 M 179,91 M 325,09 M 460,73 M
Current Assets 375,05 M 495,68 M 742,05 M 852,07 M 1,10 B
Current Liabilities 72,83 M 66,30 M 95,03 M 263,34 M 71,71 M